Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

BACKGROUND: The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In November 2021, the Omicron variant was discovered and immediately classified as a variant of concern (VOC), since it shows substantially more mutations in the spike protein than any previous variant, especially in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schubert, Maren, Bertoglio, Federico, Steinke, Stephan, Heine, Philip Alexander, Ynga-Durand, Mario Alberto, Maass, Henrike, Sammartino, Josè Camilla, Cassaniti, Irene, Zuo, Fanglei, Du, Likun, Korn, Janin, Milošević, Marko, Wenzel, Esther Veronika, Krstanović, Fran, Polten, Saskia, Pribanić-Matešić, Marina, Brizić, Ilija, Baldanti, Fausto, Hammarström, Lennart, Dübel, Stefan, Šustić, Alan, Marcotte, Harold, Strengert, Monika, Protić, Alen, Piralla, Antonio, Pan-Hammarström, Qiang, Čičin-Šain, Luka, Hust, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890955/
https://www.ncbi.nlm.nih.gov/pubmed/35236358
http://dx.doi.org/10.1186/s12916-022-02312-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890955/
https://www.ncbi.nlm.nih.gov/pubmed/35236358
http://dx.doi.org/10.1186/s12916-022-02312-5

Ejemplares similares